 |
 Play Video: The Importance of Insider Buying
|
|
|
| Date | Insider | Price | Amount |
|---|
12-22-2023
Insider Buy |
Kelly T. McKee Jr.
Chief Medical Officer |
$0.36
CAGR »
|
$2,499.84
6,944 shares |
9-25-2023
Insider Buy |
Kelly T. McKee Jr.
Chief Medical Officer |
$0.52
CAGR »
|
$5,019.56
9,653 shares |
8-25-2023
Insider Buy |
David A. Dodd
President, CEO |
$0.57
CAGR »
|
$19,999.59
35,087 shares |
8-18-2023
Insider Buy |
Mark Reynolds
CFO |
$0.52
CAGR »
|
$5,179.00
10,000 shares |
4-24-2023
Insider Buy |
David A. Dodd
President, CEO |
$0.64
CAGR »
|
$20,444.80
32,000 shares |
4-20-2023
Insider Buy |
Mark Reynolds
CFO |
$0.63
CAGR »
|
$5,040.00
8,000 shares |
9-21-2022
Insider Buy |
Randal D. Chase
Director |
$1.10
CAGR »
|
$11,000.00
10,000 shares |
6-27-2022
Insider Buy |
Kelly T. McKee Jr.
Chief Medical Officer |
$1.12
CAGR »
|
$4,999.68
4,464 shares |
6-21-2022
Insider Buy |
Randal D. Chase
Director |
$1.21
CAGR »
|
$12,100.00
10,000 shares |
5-5-2022
Insider Buy |
Kelly T. McKee Jr.
Chief Medical Officer |
$0.72
CAGR »
|
$6,999.84
9,722 shares |
9-29-2020
Insider Buy |
Randal D. Chase
Director |
$5.00
CAGR »
|
$83,065.00
16,613 shares |
9-29-2020
Insider Buy |
Dean G. Kollintzas
Director |
$5.00
CAGR »
|
$59,935.00
11,987 shares |
9-29-2020
Insider Buy |
John N. Spencer Jr.
Director |
$5.00
CAGR »
|
$105,120.00
21,024 shares |
9-29-2020
Insider Buy |
Robert T. McNally
Director |
$5.00
CAGR »
|
$269,625.00
53,925 shares |
9-29-2020
Insider Buy |
David A. Dodd
President, CEO |
$5.00
CAGR »
|
$409,350.00
81,870 shares |
9-29-2020
Insider Buy |
Mark Reynolds
CFO |
$5.00
CAGR »
|
$300,920.00
60,184 shares |
5-5-2015
Insider Buy |
Randal D. Chase
Director |
$0.19
CAGR »
|
$1,899.50
10,000 shares |
4-23-2015
Insider Buy |
Mark Reynolds
CFO |
$0.17
CAGR »
|
$5,215.00
30,000 shares |
4-20-2015
Insider Buy |
Randal D. Chase
Director |
$0.17
CAGR »
|
$5,100.00
30,000 shares |
4-20-2015
Insider Buy |
John N. Spencer Jr.
Director |
$0.17
CAGR »
|
$3,015.00
18,000 shares |
1-31-2012
Insider Buy |
Mark Reynolds
CFO |
$0.67
CAGR »
|
$10,050.00
15,000 shares |
1-16-2012
Insider Buy |
Steven S. Antebi
Director |
$0.67
CAGR »
|
$20,100.00
30,000 shares |
12-30-2011
Insider Buy |
Mark Reynolds
CFO |
$0.67
CAGR »
|
$10,050.00
15,000 shares |
12-30-2011
Insider Buy |
Robert T. McNally
President/CEO |
$0.67
CAGR »
|
$19,999.50
29,850 shares |
12-30-2011
Insider Buy |
Harriet L. Robinson
Chief Scientific Officer |
$0.67
CAGR »
|
$100,000.18
149,254 shares |
12-30-2011
Insider Buy |
David A. Dodd
Director |
$0.67
CAGR »
|
$75,040.00
112,000 shares |
12-30-2011
Insider Buy |
Dean G. Kollintzas
Director |
$0.67
CAGR »
|
$9,999.75
14,925 shares |
12-30-2011
Insider Buy |
John N. Spencer Jr.
Director |
$0.67
CAGR »
|
$9,999.75
14,925 shares |
Also See: Institutional Holders of GOVX
Also See: SEC filings
Below we present the annualized performance delivered by GOVX stock since 12-22-2023 (the date of the most recent
insider purchase). The performance of the investment from the time GOVX insider buying occurred is the ultimate
test of whether insiders were right about GOVX being a good buy.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
12/26/2023 |
|
| End date: |
04/26/2024 |
|
| Start price/share: |
$5.48 |
|
| End price/share: |
$1.42 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-74.09% |
|
| Annualized Gain: |
-223.49% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$2,591.00 |
|
| Years: |
0.33 |
|
GOVX Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.),
and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these
categories, but instead file their holdings quarterly on the latest form 13F filings.
While recent GOVX insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding GOVX
|
|
Free GOVX Email Alerts:
